Sugi Predict

Sugi Predict / Compounds / SCHEMBL2180150

SCHEMBL2180150

SCHEMBL2180150

CC(C)(O)c1cc(F)c(-c2nc(C(N)=O)c(Nc3ccc(S(C)(=O)=O)cn3)s2)c(F)c1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 9/20 0.47
▸ JAK3 P52333 6/20 0.40
▸ KCNH2 Q12809 1/20 0.40
▸ JAK1 P23458 5/20 0.39
▸ TYK2 P29597 5/20 0.39
▸ BTK Q06187 3/20 0.38
▸ CCNA2 P20248 1/20 0.33
▸ CDK2 P24941 1/20 0.33
▸ CDK5 Q00535 1/20 0.33
▸ CDK5R1 Q15078 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.32
▸ GAA P10253 1/20 0.32
▸ CSF1R P07333 1/20 0.32
▸ PTGDR2 Q9Y5Y4 1/20 0.32
▸ LRRK2 Q5S007 1/20 0.32
▸ CFTR P13569 1/20 0.32
▸ PDE4B Q07343 1/20 0.31
▸ GCK P35557 1/20 0.31
▸ GCKR Q14397 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1248438 0.89 JAK2 (0.43) JAK2JAK3KCNH2TYK2BTK
SCHEMBL1248381 0.85 JAK2 (0.50) JAK2JAK3KCNH2BTKLRRK2
SCHEMBL1246903 0.84 JAK2 (0.42) JAK2JAK3KCNH2JAK1TYK2
SCHEMBL3508574 0.83 JAK2 (0.65) JAK2JAK3KCNH2JAK1TYK2
SCHEMBL1248345 0.80 JAK2 (0.44) JAK2JAK3KCNH2
SCHEMBL3512562 0.76 JAK2 (0.62) JAK2JAK3KCNH2JAK1TYK2
SCHEMBL1248346 0.75 JAK2 (0.42) JAK2JAK3KCNH2
SCHEMBL14699729 0.74 JAK2 (0.38) JAK2JAK3KCNH2
SCHEMBL2178927 0.74 TBK1 (0.43) JAK2JAK3KCNH2
SCHEMBL2178450 0.72 JAK2 (0.74) JAK2JAK3KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2278969-B1 Inhibitors of Janus kinases MERCK SHARP & DOHME (US) 2013-02-13 — — EP claimed
US-8278335-B2 Inhibitors of Janus kinases MERCK SHARP & DOHME CORP. (US) 2012-10-02 — — US claimed
US-20110166129-A1 INHIBITORS OF JANUS KINASES MERCK SHARP & DOHME LLC 2011-07-07 — — US claimed
EP-2278969-B1 Inhibitors of Janus kinases MERCK SHARP & DOHME (US) 2013-02-13 — — EP disclosed
EP-2278969-B1 Inhibitors of Janus kinases MERCK SHARP & DOHME (US) 2013-02-13 — — EP disclosed
US-8278335-B2 Inhibitors of Janus kinases MERCK SHARP & DOHME CORP. (US) 2012-10-02 — — US disclosed
US-8278335-B2 Inhibitors of Janus kinases MERCK SHARP & DOHME CORP. (US) 2012-10-02 — — US disclosed
US-8278335-B2 Inhibitors of Janus kinases MERCK SHARP & DOHME CORP. (US) 2012-10-02 — — US disclosed
US-20110166129-A1 INHIBITORS OF JANUS KINASES MERCK SHARP & DOHME LLC 2011-07-07 — — US disclosed
US-20110166129-A1 INHIBITORS OF JANUS KINASES MERCK SHARP & DOHME LLC 2011-07-07 — — US disclosed
US-20110166129-A1 INHIBITORS OF JANUS KINASES MERCK SHARP & DOHME LLC 2011-07-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166129-A1 INHIBITORS OF JANUS KINASES JAK2, JAK3, JAK1 JAK2 1/4885JAK3 2/4885KCNH2 1568/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.